Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Multi-mode Ablation Combined with Sintilimab for Colorectal Cancer Liver Metastasis
NCT06590259Phase 2Recruiting
- Sponsor
- Shanghai Sixth People's Hospital
- Start
- Mar 2024
- Primary completion
- Jul 2027
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of sintilimab in colorectal cancer (CRC), sponsored by Shanghai Sixth People's Hospital. Started Mar 2024; status: recruiting.
02
Drugs
sintilimab
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT06590259.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06590259.